Cargando…
Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
Pyoderma gangrenosum (PG) is a rare, autoinflammatory disease leading to aseptic ulcers which carries a significant disease burden and is often difficult to treat, with many patients failing first-line treatment and requiring additional therapies. Such cases are typically referred to in the literatu...
Autores principales: | Becker, Sarah L, Velasco, Rose, Ortega-Loayza, Alex G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423579/ https://www.ncbi.nlm.nih.gov/pubmed/37581011 http://dx.doi.org/10.2147/CCID.S381490 |
Ejemplares similares
Ejemplares similares
-
Adalimumab Therapy for Recalcitrant Pyoderma Gangrenosum
por: Fonder, Margaret A., et al.
Publicado: (2006) -
Pyoderma Gangrenosum: Treatment Options
por: Dissemond, Joachim, et al.
Publicado: (2023) -
Modified dose of guselkumab for treatment of pyoderma gangrenosum
por: Reese, Ashley M., et al.
Publicado: (2022) -
Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum
por: Baier, Cassandra, et al.
Publicado: (2020) -
Pyoderma gangrenosum: a review with special emphasis on Latin America literature()()
por: Rodríguez-Zúñiga, Milton José Max, et al.
Publicado: (2019)